Background: Because the causes of stones are uncertain, interventions to prevent recurrence have an insecure foundation. Progress depends on careful evaluation of stone formers. Methods: A descriptive retrospective database study of 1983 men and 816 women from the Southampton stones clinic from 1990 to March 2007. Anonymized data from the first attendance were analysed using non-parametric statistical tests. Results: Sex ratio (2.43:1), age (median 49 y, 2.5th -97.5th percentiles, 23-77 y men, 20-79 y women), recurrent stone formers (30%) and type of stone were similar to other centres. Women more often had a positive family history (24% versus 19% men), previous urinary infection (31% versus 5%) and structural urinary tract abnormality (14% versus 7%); more men had gout (5% versus 1%) and bladder outlet obstruction (3% versus ,1%). Calcium, oxalate and uric acid excretion were increased in 43%, 17% and 22% respectively of men and 31%, 7% and 10% of women. Urinary calcium, oxalate and uric acid correlated significantly, r ranging from 0.149 to 0.311 for 24 h excretion and 0.510 to 0.695 for concentrations per litre. Twenty-two percent of men and 8% of women with normal parathyroid hormone had phosphaturia (excretion of phosphate corrected for glomerular filtration rate (TmPO 4 /GFR) , 0.70 mmol/L); 6% men and 1.6% women also had low plasma phosphate. Many variables correlated significantly but often weakly with age. Creatinine clearance, pH and (men) TmPO 4 /GFR decreased from 50 y, urine creatinine, calcium and citrate from 60 y. Conclusions: Risk factors for stones differ between men and women, change with ageing and in some may have a genetic basis. The role of phosphaturia merits further exploration.
Introduction
Kidney stones are common. In America, the life-time risk for men is 12% and for women 5% 1 with estimated annual incidences for men ranging from 100 to 300 per 100,000. 2 They are 2-4 times commoner in men than in women 2 and their prevalence has risen over the last 40 y. 3, 4 There is a high recurrence rate, estimated at around 25% in 10 y for a first time stone former and 75% for recurrent stone formers. 5 Passage of a kidney stone is extremely painful and may require surgical intervention. The unpredictability of recurrent episodes may affect the quality of life and career choice. The costs of medical and surgical procedures plus costs from loss of work are considerable. 6 There are therefore, strong incentives to prevent recurrence.
The majority of stones (around 75 -80%) contain calcium salts, generally calcium oxalate often with calcium phosphate. In total, 5 -10% of stones are uric acid and there are rare inherited stones. 1, 3, 5 Many factors contribute to stone formation and often more than one is involved in individual patients. These include abnormally high excretion of stone constituents, poor fluid intake, alteration in urine pH and decreases in protective urinary components. 1, 7 Around 20% of stone formers have a family history of stones, probably indicative of a genetic predisposition. 1, 4, 8 Medical disorders including urinary infections, diabetes and inflammatory bowel disease increase the risk for stones. 2, 5 A focused history and selective biochemical investigation of stone formers in outpatient clinics will often reveal abnormalities of life-style or metabolism which increase the risk for more stones. Management to prevent recurrence can then be tailored to the individual and has been shown to be clinically effective 1 and cost-saving. 9 Because of the uncertainty of the causes of stones, however, preventive measures have an insecure evidence base, are controversial and sometimes inappropriate. 6, 10 Low calcium diets, formerly advised widely, are associated with increased stone production. 11 Progress can only stem from careful evaluation of stone formers, including relevant biochemistry. There are published reports of observations on large cohorts of stone formers investigated in research centres in America and Europe 12 -15 and the UK. 3 These have often focused on subsets of patients. There have been no recent reports from a large British clinic.
The Stones Clinic in Southampton was established in the 1970s to advise about preventing stone recurrence. There are very few similar clinics in the UK. This report presents an overview of demographic and biochemical data of 2800 patients from their first clinic attendance between 1990 and 2007. Data for subsets of stone formers will be reported separately.
Samples
At the first clinic attendance, 8 mL of non-fasting blood was collected routinely into both a lithium heparin tube and plain tube and a paired fresh random urine sample into a sterile container. The blood was centrifuged within 30 min of collection. Patients were instructed carefully about collecting a 24 h sample of urine directly, or via a sterile jug, into a new polythene container containing thymol crystals as preservative. On receipt in the laboratory, the 24 h urinary volume was determined from weight, an aliquot was removed for uric acid analysis and the urine remaining in the container was then acidified with 6 mol/L hydrochloric acid to pH 2.00 for other analyses. The standard tests for the clinic were: plasma: electrolytes, bicarbonate, creatinine, calcium adjusted for albumin, phosphate, alanine transaminase, alkaline phosphatase and parathyroid hormone (PTH); fresh random urine: pH, phosphate and creatinine concentrations; 24 h urine sample: volume, calcium and oxalate. Urine uric acid, citrate and magnesium were added variably, often for patients with more severe stone problems or with associated medical disorders.
Analyses
Samples were analysed by the Clinical Chemistry Department at Southampton General Hospital with assays used routinely. With the exception of PTH, all the plasma measurements and urine phosphate, creatinine, calcium, magnesium and uric acid analyses employed one of three main automated systems in use during the study: DAX (Bayer Diagnostics, Tarrytown, NY, USA), Advia 1650 (Bayer Diagnostics) and from the end of 2006 Beckman-Coulter DXC800 (Beckman Coulter Instruments Inc, Fullerton, CA, USA). The methods correlated well on all three instruments without need to alter reference limits. Calcium was measured with o-cresol phthalein complexone until introduction of an ion-selective electrode method late in 2006, magnesium with xylidyl blue or calmagite and uric acid with uricase procedure. Inter-assay imprecision (coefficient of variation) was ,2% for plasma assays except creatinine (,5%), ,3% for urinary phosphate and ,5% for urinary creatinine, magnesium and uric acid. Citrate was measured with a citrate lyase procedure 16 using a Boehringer Mannheim Diagnostics Kit (Roche, Welwyn Garden City, UK). After removing interferences with activated charcoal, oxalate was measured by an oxalate oxidase method with a Sigma Diagnostics Kit (Sigma-Aldrich Company Ltd, Poole, UK) or Thermo Scientific Oxalate Kit (Alphalaboratories, Hampshire, UK). Cobas Mira (Roche, Welwyn Garden City, UK) and later Beckman-Coulter DXC800 analysers were used for both oxalate and citrate analyses and inter-assay variation was ,5% and ,10%, respectively. Intact PTH was measured using Immulite 2000 and 2500 Analysers (DPC, Gwynedd, UK) with a chemiluminescent immunometric method using Immulite kits. Three kits with small differences in sensitivity were used during the study period. Most samples were analysed with the first (up to December 2001). The second was used in 2002 and 2003, and the third from 2004. Inter-assay variation was ,10%, recovery 100 + 10%. All the assays performed well in external quality assessment schemes (WEQAS, UK NEQAS [PTH]). The pH of fresh urine was measured using a glass electrode (Whatman PHA 400 pH meter; Whatman, Maidstone, Kent, UK or Checker 1 pH meter; Hanna Instruments, Leighton Buzzard, UK). Stones were analysed qualitatively, with chemical methods using a Merckognost urinary calculi analysis kit (Merck, Darmstadt, Germany), with good performance in a National quality assurance scheme, UCL renal calculi QA scheme (University College, London, UK). TmPO 4 /GFR was calculated from phosphate and creatinine concentrations of paired plasma and random urine samples using a computer programme. 17, 18 For an approximation of fractional calcium excretion, filtered calcium was assumed to be 60% of total plasma calcium (50% ionized and approximately 10% complexed) and used to calculate the ratio of calcium clearance to creatinine clearance.
Data analysis
Microsoft Excel (97-2003) was used to process the data, calculate mean and median values and 2.5th and 97.5th percentiles.
Few of the raw and log-transformed data had a Gaussian distribution (D'Agostino -Pearson test) and non-parametric statistical analyses were applied universally: Spearman's rank test to look for significant correlation between biochemical indices, and the two-tailed Mann-Whitney U test and two-sided Fisher's exact test or Chi-square tests to compare differences between groups. Graph Pad Prism 5 version 5.04 and Graph Pad Instat 3 (GraphPad, La Jolla, CA, USA) were used for the statistical computations.
Results

Demographics
There were 2903 patients on the database. Of these, 104 were excluded because of duplicate entries, omission of gender or obvious errors in the date of birth. The final cohort comprised 2799 patients: 1983 men and 816 women (ratio of men to women 2.43:1), of whom 847 (30%) had produced stones on more than one occasion and were classed as recurrent stone formers. There were clinical entries for only 65% of women and 58% of men. Frequencies of clinical disorders are expressed as the percentage of the patients with recorded data and not of the full cohort. Structural urinary tract abnormalities included congenital abnormalities, single kidneys as a result of nephrectomy and multiple, but not single, renal cysts. Haematological abnormalities were uncommon and encompassed a miscellaneous group: leukaemia, thalassaemia, myeloma and lymphoma. Table 1 summarizes the data. Findings of interest were:
(1) The surprisingly high percentage of patients (24% of women, 19% of men) with one or more first-degree relatives with stones. Fourteen women and 10 men had three or more affected relatives; (2) The large percentage of women (31%) with a history of urinary infections compared with men (5%); (3) The occurrence of large staghorn calculi in 11 women (seven required nephrectomy) but only one man. He and five women had recorded urinary infections; (4) Higher frequencies of gout, bladder outlet obstruction (generally due to prostatic enlargement) and diabetes in men and structural urinary tract abnormalities in women; (5) The high proportion of patients (20%) who took vitamin D supplements, generally over-the-counter preparations of cod liver oil or similar. Thirty-one women took a calcium preparation. (6) Current or previous primary hyperparathyroidism in 5% of patients. (7) The higher frequency of pure calcium oxalate stones in men and mixed calcium, oxalate, phosphate stones in women.
Plasma and urine biochemistry
Overview Table 2 presents data for plasma and random urine for the full cohort and for 24 h urine after excluding collections which were probably incomplete 19 Calcium, oxalate and uric acid excretion were significantly correlated, with stronger association for concentration than for 24 h excretion ( Table 3 ). Citrate excretion and urinary pH were not significantly correlated.
Features of note were the significant sex differences observed for some plasma and urine constituents, the higher frequency of abnormalities associated with stones risk in men than in women, the high frequency of phosphaturia as defined by low TmPO 4 /GFR and of hypocitraturia, and the collective increases in abnormalities with low fluid intakes.
Sex differences
(1) Plasma and urine creatinine and creatinine clearance were higher in men; (2) Plasma bicarbonate was higher in men but the difference between median concentrations was small; 
Phosphaturia
A high percentage of patients had TmPO 4 /GFR below the reference limit of 0.80 mmol/L. 17 After excluding patients with absent or abnormal PTH results (see 3 above) TmPO 4 /GFR was ,0.80 mmol/L for 44% of men and 24% of women (P , 0.0001), and applying a lower threshold of ,0.70 mmol/L, 20 
Changes in biochemistry with age
There were weak correlations between the ages of stone formers and their measured urine variables (Table 4 ). Of interest were the negative correlations for urine pH and TmPO 4 /GFR, particularly in men.
Data for each decade were examined after excluding patients with clinical disorders, medications and supplements which may alter mineral metabolism (Tables 5  and 6 ). Men were noted to have a progressive increase in urine volume with age, decreases in creatinine clearance, urine pH and TmPO 4 /GFR over 50 y and in 24 h urine calcium, citrate and creatinine over 60 y. There was little 
Discussion
The first attendance at the Southampton stones clinic is a triage assessment to distinguish between patients with no, or only minor, biochemical risks for stones who merely require dietary and life-style advice, and those who require further investigation and preventive management. A relatively simple investigation protocol was implemented to cause minimal inconvenience for the patients. This is the largest cohort of stone formers from a UK clinic to be reported recently. Because it was a single centre study there was consistency in investigative protocols and laboratory analyses.
The study has certain limitations. The quality of the primary data from the clinics varied, with variation among the consultants in eliciting and recording clinical details. Height and weight were not recorded routinely. Non-fasting blood and urine samples were collected at the clinic. Although a central core of biochemistry tests was the norm, requests for 24 h urine uric acid, magnesium and citrate varied among consultants, were often selected for more complex patients and the results may not represent the full patient cohort. There were deficiencies in the database, particularly in entries of relevant clinical details and medications. These could not be rectified because the data were anonymized. However, the effects of incomplete data were largely over-ridden by the large number of patient results and probably had little impact on the overall conclusions.
Demography
The ratio of men to women of 2.43:1 and age at presentation agreed closely with other clinics. 2, 21, 22 Thirty-three percent of men and 23% of women were recurrent stone formers, in line with other reports. 2, 5 Most stones produced were calcium oxalate (89%) with a 1:4 ratio of calcium to oxalate to mixed calcium oxalate phosphate stones. Pure calcium phosphate stones were rare (2%). These are similar to frequencies in the USA, Northern Europe and Australia. 1, 2, 5 Uric acid stones (4%) were less common than 5 -23% reported, as was the incidence of struvite stones (,2%) compared with 5 -15%reported. 1, 2 The referral practices, population, dietary characteristics and period of study all influence the clinic stones profiles. Mixed calcium oxalate phosphate stones were commoner in women but phosphate was not quantified. A higher frequency of stones containing .50% of phosphate was reported in women. 23 As in other studies, pure calcium oxalate stones were commoner in men and struvite stones in women; however, uric acid stones were not increased in Table 5 Continued 13-20 y, n Table 6 Urine and stones biochemistry of 509 women according to age decades men. 2, 22 The incidences of past or current primary hyperparathyroidism and of presumptive hyperparathyroidism from tests at the clinic are in line with reported frequencies of 2-8% and 1.65-13.3% of stone formers. 24, 25 The surprisingly high percentage of patients with a firstdegree relative with stones is similar to reported frequencies of 16.8% of men and 22.7% of women with stones compared with 6% of controls, 2 and indicate that genetic factors are implicated in stone formation in some kindreds. 1, 4, 8 The complexity of mineral and phosphate absorption, turnover and excretion has become increasingly apparent and the long list of genes involved is extending. Inherited pathological gene mutations associated with hypercalciuria, phosphaturia and impaired hydrogen ion excretion are wellrecognized. Common polymorphisms of these and other genes may explain the heritable risk. 1, 4, 8, 26 There were clear differences between men and women in the frequency of disorders which increase stones risk. The most striking was the large percentage of women who had previous urinary tract infections. This is perhaps a little surprising since stones are commoner in men and might provide a nidus for infection. Female anatomy is more likely to account for the increase in the majority of cases. Structural abnormalities of the urinary tract affecting urine flow were probably responsible in a minority. Infection stones are commoner in women. 22 Very few women had symptomatic infections at the clinic prompting bacteriological investigation, and the incidence of struvite stones in the cohort was low. Inflammatory processes associated with previous infections might be implicated in stone formation. 27 Eleven women but only one man had large damaging staghorn stones which are commonly attributable to infection (44% in a recent series 28 ).
Twenty percent of patients took vitamin D supplements, generally cod-liver oil or similar preparations with a low vitamin D content (400 IU in most standard formulations), some of which also contained small amounts of calcium. It is highly unlikely that such low doses had a significant impact on urine biochemistry or stones risk. However, three of 30 women taking a calcium supplement had significantly increased urinary calcium. Since calcium and vitamin D supplements were found to increase stones frequency in postmenopausal women, 29 it seems advisable to measure 24 h urine calcium of stone formers receiving calcium treatment.
Abnormalities of urine biochemistry associated with stones risk
Urinary abnormalities which increase stones risk were frequent and were commoner in men. Twenty-four hour calcium excretion is a continuous variable. There is no clear cut-off between normal and abnormal 30 and the widely used reference limits of 7.50 mmol/24 h for men and 6.25 mmol/24 h for women are arbitrary. 1, 7 Hypercalciuria, hyperoxaluria and hyperuricosuria were commoner in men than in women, with similar frequencies to other cohorts. 2, 4, 7, 31 An important observation was that excretion of calcium, oxalate and urate were significantly correlated, with stronger association between urine Table 6 Continued 15 -20 y, n concentrations than 24 h excretion. In a small subset of patients with complete data, the proportion with collective increases in all three increased from 3% for 24 h excretion to 20% when concentrations were expressed per litre. Those patients with normal 24 h excretion but increased concentrations had low urinary volumes, often less than 1 L/24 h, demonstrating the risk of an inadequate fluid intake. Collective increases in concentration of all three stones constituents will increase urine supersaturation and increases stones risk significantly. 19 While measurement of 24 h urine excretion is essential for metabolic diagnosis, concentrations per litre should also be calculated as a more appropriate guide for stones prevention. 19 Achieving a safe urine volume in patients with an ileostomy may be difficult.
Hypocitraturia is listed as a major cause of calcium stones. 1, 7, 15 With lower limits of 2.0 and 1.7 mmol/24 h, two studies reported hypocitraturia in 30% and 32.7% of recurrent stone formers. 7, 32 However, one large study found no difference in citrate excretion between stone formers and controls. 19 Almost 50% of Southampton patients had citrate excretion below the lower reference limit of 1.52 mmol/L, derived in-house from healthy laboratory staff and students and, contrary to expectation, there was no correlation with urine pH. 33 The assay performed well in the external quality assessment scheme, and thymol in the collection container protected against preanalytical bacterial degradation. The explanation for low measured citrate in stone formers is unknown. Underestimation of complexed citrate in the enzyme-based assay might be a possibility. The high positive rate limits its value for decision-making in a triage clinic.
Magnesium may also have a protective role in calcium stone formation. 7 Urine magnesium was measured in only a small proportion of clinic patients and only three had low levels, in line with a reported incidence of only 4% in recurrent stone formers 31 and of no major differences between stone formers and controls. 7 Magnesium analysis could be restricted to those at risk of depletion from intestinal disorders or chronic diuretic use, or with a possible genetic defect.
Phosphaturia
The renal threshold of phosphate concentration (TmPO 4 / GFR) is a practical means of assessing overall tubular capacity for tubular phosphate re-absorption which is independent of GFR. 17 Low values indicate phosphaturia. Considering only patients with biochemical evidence of normal parathyroid function, phosphaturia was common among stone formers in this study, even applying the low threshold of TmPO 4 /GFR ,0.70 mmol/L. 20 Analysis of non-fasting samples may have contributed to the high frequency. Although 24 h urine phosphate is measured in clinics, this largely reflects dietary phosphate. Data on phosphaturia in stone formers are sparse. 7 Calcium stone formers with normal PTH have lower TmPO 4 /GFR than normal subjects. 34 In around 20%, both plasma phosphate and TmPO 4 /GFR are low, consistent with a renal phosphate leak, 20 found in 6% of men and 1.6% of women in this cohort using criteria for fasting samples. 20 When renal phosphate re-absorption is reduced a large intake of phosphate will increase phosphaturia, calcium salt supersaturation and the risk of forming calcium stones. Since calcium phosphate precipitation increases with increasing pH, 1, 7, 35 the risk might be greatest postprandially, if an influx of phosphate is combined with increased urine pH (the alkaline tide) which some, but not all, 36 have observed after meals. There is evidence that calcium phosphate deposition initiates calcium oxalate stone formation. 1, 7, 35 Phosphate supplements to correct low plasma phosphate levels may be inadvisable because of the increased risk for stones.
The explanations for the high frequency of phosphaturia among stone formers without hyperparathyroidism and its commoner occurrence in men are unknown. Around 80% of circulating phosphorus is filtered at the glomerulus and then 70 -100% is actively re-absorbed in the proximal tubule under hormonal control and influenced by volume and acid-base status. 37, 38 Most phosphate re-absorption is via the sodium-phosphate co-transporter Npt2a which is inhibited by the principal phosphaturic hormone FGF23 in conjunction with a co-factor, klotho. 38 Genetic variation in any of the factors involved in this complex system might account for phosphaturia and increases in serum FGF23, observed in stone formers with phosphate leak. 20 Changes in biochemical risk factors with age Comparable with this study, urinary calcium, uric acid, citrate and pH decreased in stone formers over 60 y. 15 Similar trends were observed in healthy non-stone formers for urine calcium, uric acid, pH and (women only) citrate; 21 however, their urine volume decreased. Stone formers may have deliberately increased their fluid intake or have decreased renal water re-absorption. Others have reported falling pH with age in normal individuals 39 and stone formers. 14, 15 The explanation is unknown. Decreased renal ammonia production has been proposed, 39, 40 possibly attributable to insulin resistance with decreased activity of glutaminase and of the NHE3 Na þ /H þ exchanger in the proximal tubule. 40 A urinary pH persistently ,5.5 significantly increases the risk of uric acid precipitation 1,5 and probably underlies the higher incidence of uric acid stones in patients over 60 y as found in this cohort. 22 Dissolution of phosphate from mixed calcium oxalate phosphate stones at low pH 5 might explain the fall in the ratio of mixed to pure calcium oxalate stones observed in older women. To our knowledge, decreasing TmPO 4 /GFR with age has not been reported. It may be a consequence of declining renal function.
Summary
Many women did not have a demonstrable biochemical abnormality to explain their stones and other factors must be sought. The high incidence of previous urinary infections, structural abnormalities of the urinary tract and possibly genetic factors may be relevant. Significant correlation between calcium, oxalate and uric acid excretion, reported by few centres, is important. Phosphaturia similarly is under-reported but, particularly in men, would be consistent with emerging concepts of stone formation.
